Business Context and Reporting Period
Company: RYVYL Inc. (Note: Input metadata referenced "RTB Digital, Inc.", but the filing text identifies the registrant as RYVYL Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: January 23, 2025
Reporting Period: Events occurring on January 23, 2025, with a press release issued January 24, 2025.
The Company entered into a series of material agreements to restructure debt obligations and secure financing through the sale of a subsidiary.
Key Financial Metrics and Agreements
- Debt Repurchase Obligation: Total consideration of $17,000,000 to repay an 8% Senior Convertible Note and repurchase Series B Convertible Preferred Stock.
- Financing Proceeds: $15,000,000 purchase price for the sale of all issued and outstanding shares of Ryvyl (EU) EAD ("Ryvyl EU").
- Payment Structure:
- First Installment: $13,000,000 due within 48 hours of financing receipt or by January 27, 2025 (extendable to February 3, 2025 for an additional $50,000).
- Second Installment: $4,000,000 (or $4,050,000 if extension is used) due by April 30, 2025.
- Termination Liability: Potential liability of $16,500,000 if the Company terminates the Stock Purchase Agreement (SPA) or fails to close due to non-breach reasons.
Material Changes and Transactions
Debt Restructuring: The Company agreed to settle an 8% Senior Convertible Note (originally due November 2023, extended to April 2026) and repurchase 55,000 Series B Preferred Shares. Upon payment of the first installment, interest accrual on the remaining balance is suspended, and restrictive covenants are temporarily waived.
Asset Sale: The Company agreed to sell its indirect Bulgarian subsidiary, Ryvyl EU, to a Purchaser for $15,000,000. The proceeds are escrowed and must be used to fund the first installment of the debt repayment.
Contingent Obligations: A Termination Agreement allows the Company to void the asset sale by paying $16,500,000 within 90 days. Conversely, if the Purchaser cannot close due to regulatory issues or other non-breach reasons, the Company is liable for $16,500,000 in damages.
Guidance, Risks, and Unusual Items
- Liquidity Risk: The repayment of the Note is contingent on the successful closing of the $15,000,000 financing. If the financing fails, the Company must still meet the debt obligations or face default.
- Regulatory Risk: The SPA closing is subject to regulatory clearances. Failure to obtain these clearances triggers a $16,500,000 liability to the Purchaser.
- Interest Accrual: If the Second Installment is not paid by April 30, 2025, interest will resume accruing on the outstanding balance, and all original Note terms will be restored.
- Unusual Item: The filing involves a complex "sale-to-repay" structure where the sale of a foreign subsidiary is directly tied to the extinguishment of senior debt and preferred equity.
Investor Verification Checklist
- Confirm the status of the $15,000,000 financing escrow and whether funds have been deposited by January 28, 2025.
- Verify if the $13,000,000 First Installment was paid by the January 27, 2025 deadline or if the extension option was exercised.
- Assess the likelihood of obtaining necessary regulatory clearances for the transfer of Ryvyl EU shares to avoid the $16.5 million termination liability.
- Review the full text of the Repurchase Agreement (Exhibit 10.1) for specific covenants waived during the interim period.
- Monitor the Company's cash position to ensure the ability to fund the $4,000,000 Second Installment by April 30, 2025.